Skip to content
Study at Cambridge
About the University
Research at Cambridge
Services
Connecting Cambridge Innovation
Academic Consultancy Services
Pioneering Research Innovations
Venture Building & Investment
About
Who we are
Our team
Our performance
Careers
The Cambridge Ecosystem
Beyond the University
Partnerships and collaboration
FAQs
Stories
Events
Publications
Contact
Search
Search
Menu
Archive
Posts Tagged ‘Morphogen-ix’
Case Studies
Centessa Pharmaceuticals: Three portfolio companies merge into a new pharmaceutical giant
16 February 2022
News
2021 Annual Review reports success for Cambridge Enterprise
27 January 2022
News
Three Cambridge spin-outs join Centessa Pharmaceuticals, launched today with a $250m Series A round
16 February 2021
News
Spin-out Morphogen-IX raises £18.4m in a Series B financing
18 December 2018
News
Spin-out Morphogen-IX announces its clinical development candidate
27 November 2018
News
Spin-out Morphogen-IX announces appointment of CEO and SAB members
28 June 2018
Case Studies
New potential treatment for pulmonary arterial hypertension
23 May 2016
News
Morphogen-IX gains funding to develop treatment for PAH
18 January 2016
1-8 of 8
Page
1
1
of 1
